ENJASDI owner Contact Information online
from Glaxo Group Limited
ENJASDI
US serial number:87201024
Application filling date:Oct. 12, 2016
Register:Principal
Mark type:Trademark
Status:Application has been published for opposition. The opposition period begins on the date of publication.
Status date:Jan. 17, 2017
Publication date:Jan. 17, 2017
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Foreign foreign registration number:3152568
Foreign foreign registration date:Mar. 02, 2016
Foreign foreign application registration country:UNITED KINGDOM
Foreign foreign expiration date:Mar. 02, 2026
Goods and services:For: Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive
Current owner owner name:Glaxo Group Limited
Current owner owner address:980 Great West Road
Brentford, Middlesex
ENGLAND
TW89GS
Current owner legal entity type:private company limited by shares (prc)
Current owner state or country:ENGLAND
Attorney name:Angela L. Wilson
Attorney email:trademarks@gsk.com
Attorney docket number:81969466/klm
Attorney email authorized:Yes
Correspondent name address:ANGELA L. WILSON
GSK
5 MOORE DRIVE, LGTM, 5.5A
RESEARCH TRIANGLE PARK,
NORTH CAROLINA
UNITED STATES
27709
Correspondent phone:9195369413
Correspondent email:trademarks@gsk.com
Correspondent email authorized:Yes
Trademark staff tm attorney:SHARPER JR, SAMUEL E
Trademark staff law office assigned ENJASDI:LAW OFFICE 108
Latest trademarks
Popular owners
Glaxo Group Limited (178) Novartis AG (130) JOHNSON & JOHNSON (124) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) Windmill Health Products, LLC (46) Bayer Aktiengesellschaft (44) SANOFI (41) Wyeth LLC (41) Pfizer Inc. (39) Forest Laboratories, Inc. (34) Bristol-Myers Squibb Company (33) Vital Health Pharmaceuticals, Inc. (31) Primary Investments Group Limited (28) S. C. Johnson & Son, Inc. (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (19) Scott Riddell (17) Biocept, Inc. (16)Popular publication dates
Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Nov. 16, 2010 Apr. 19, 2011 Mar. 29, 2011 Apr. 12, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010 Apr. 05, 2011Similar brands
